tangotx.com (TNGX) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Tango Therapeutics (TNGX)

The dynamics of current cash reserves for Tango Therapeutics (TNGX) are based on strategic alliances with pharma giants to identify targets. The 0.98 mark captures this metric, which depends on the success of clinical trials rather than macroeconomics. The financial stability of Tango Therapeutics (TNGX) is supported by a flexible scientific culture and the recruitment of leading geneticists through a stock option system, ensuring the development of targeted oncology.

TNGX - Cadangan dhuwit perusahaan Tango Pharma ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Tango Therapeutics

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Tango Therapeutics Inc TNGX
Produk merek Tango Therapeutics, Inc.

By utilizing an asset-light model with outsourced drug manufacturing, Tango Therapeutics (TNGX) concentrates its resources on R&D, making liquidity a critical survival factor. Analyzing the company's cash assets allows an investor to assess its ability to cover operating expenses without external support; meanwhile, an excess of funds signals inefficient capital management, while a deficit indicates risks in the event of declining revenue.

Pesaing Tango Therapeutics (TNGX)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Iovance Corp|Immatics N.V. (IMTX) - Dana dhuwit perusahaan|Xencor, Inc. - Sisa dhuwit perusahaan|CMPX (compasstherapeutics.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Replimune Group Inc|Dana dhuwit perusahaan Lyell Immunopharma, Inc. (LYEL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan